Last reviewed · How we verify
NCT05308173: AVALON
Aortic Valve replAcement in eLective Patients From aOrtic Valve multiceNter Registry
trial testing Surgical Aortic Valve Replacement in Aortic Valve Stenosis in 2,393 participants. Completed in 30 June 2021.
30 June 2021
Quick facts
| Lead sponsor | Nicolaus Copernicus University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,393 |
| Start date | 1 January 2015 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 June 2021 |
Drugs / interventions tested
- Surgical Aortic Valve Replacement
- Transcutenous Aortic Valve Implantation
Conditions studied
- Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →
Sponsor
Nicolaus Copernicus University
Who can join
18 and older, any sex, with Aortic Valve Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multicenter registry data analysis of aortic valve stenosis patients that underwent elective, isolated transcutaneous aortic valve implantation (TAVI) or surgical aortic valve replacement between 2015 and 2019. In TAVI group only transfemoral access was considered.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05308173
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Surgical Aortic Valve Replacement
Trials testing the same drug.
- NCT04535076 — Cognitive Outcome After Surgical and Transcatheter Aortic Valve Replacement · NA · completed
Other recruiting trials for Aortic Valve Stenosis
Currently open trials in the same condition.
- NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
- NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
- NCT07145463 — Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aorti · NA · recruiting
- NCT07520656 — Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing · recruiting
- NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
Other Nicolaus Copernicus University trials
Trials by the same sponsor.
- NCT06563921 — RE and Probiotics in MAFLD/NAFLD · NA · not yet recruiting
- NCT06446258 — Assessment of the Impact of Soft Tissue Mobilization on the Scar in Patients After Cesarean Section · NA · completed
- NCT06134024 — The Role of Double Pigtail Plastic Stents During Endoscopic Transmural Drainage of Pancreatic Fluid Collections. · NA · unknown
- NCT06061432 — Endoscopic Ultrasound- Guided Hartmann Reversal Procedure · NA · not yet recruiting
- NCT04814238 — Minimally Invasive Aortic Root and Aorta surGery rEgistry · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05308173 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nicolaus Copernicus University
- Last refreshed: 1 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05308173.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing